KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 142 filers reported holding KURA ONCOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $476,028 | -20.6% | 52,196 | -7.8% | 0.06% | -21.8% |
| Q2 2023 | $599,198 | -13.5% | 56,635 | -0.0% | 0.08% | -17.9% |
| Q1 2023 | $692,817 | -1.4% | 56,649 | +0.0% | 0.10% | -7.8% |
| Q4 2022 | $702,840 | -9.2% | 56,635 | 0.0% | 0.10% | -28.0% |
| Q3 2022 | $774,000 | -25.5% | 56,635 | -0.2% | 0.14% | -45.2% |
| Q2 2022 | $1,039,000 | -98.2% | 56,724 | -93.8% | 0.26% | -66.7% |
| Q1 2022 | $56,635,000 | +7023.9% | 910,690 | +1503.0% | 0.78% | +253.2% |
| Q4 2021 | $795,000 | -25.0% | 56,813 | +0.3% | 0.22% | -25.8% |
| Q3 2021 | $1,060,000 | -10.2% | 56,635 | -0.0% | 0.30% | -23.1% |
| Q2 2021 | $1,181,000 | -19.3% | 56,656 | +9.4% | 0.39% | -27.6% |
| Q1 2021 | $1,464,000 | -19.7% | 51,792 | -7.3% | 0.54% | -19.6% |
| Q4 2020 | $1,824,000 | – | 55,869 | – | 0.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 206,307 | $3,363,000 | 11.31% |
| Foresite Capital Management IV, LLC | 1,307,982 | $21,320,000 | 10.39% |
| EcoR1 Capital, LLC | 4,608,529 | $75,119,000 | 5.55% |
| Prosight Management, LP | 685,000 | $11,166,000 | 4.79% |
| ACUTA CAPITAL PARTNERS, LLC | 872,500 | $14,222,000 | 4.11% |
| BVF INC/IL | 2,775,882 | $45,247,000 | 2.79% |
| VR Adviser, LLC | 575,000 | $9,373,000 | 2.24% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 216,171 | $3,524,000 | 2.06% |
| DAFNA Capital Management LLC | 294,260 | $4,796,000 | 1.38% |
| Vivo Capital, LLC | 1,050,000 | $17,115,000 | 1.23% |